New hope in treating PTSD with psychedelic drugs
- Nov 14, 2021
- 7:47
- Full Episode
Some service members and others suffering from Post-Traumatic Stress Disorder (PTSD) have had little relief from traditional anti-depressants used in conjunction with psychotherapy. Now, a recent FDA-approved trial using a psychedelic drug called MDMA – better known by its street name, ecstasy – has shown promising results. CBS News national security correspondent David Martin talks with a former Marine whose two tours in Iraq presaged twelve years of nightmares, panic attacks and failed relationships – and who now finds hope.
"CBS Sunday Morning" features stories on the arts, music, nature, entertainment, sports, history, science and Americana, and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.
For video licensing inquiries, contact: licensing@veritone.com
Brief Summary
Veterans discuss transformative MDMA therapy for PTSD, highlighting its potential as a breakthrough treatment.
Key points
- MDMA: A Surprising Treatment. MDMA, known as ecstasy, shows promise in treating PTSD for veterans.
- Breakthrough Designation by FDA. The FDA has designated MDMA-assisted psychotherapy as a breakthrough approach for PTSD treatment.
Episode highlights
- MDMA: A Surprising TreatmentMDMA, known as ecstasy, shows promise in treating PTSD for veterans.“It really did change my life.”2:12Nov 14, 2021
- Breakthrough Designation by FDAThe FDA has designated MDMA-assisted psychotherapy as a breakthrough approach for PTSD treatment.“What does the breakthrough mean to me?”7:24Nov 14, 2021






